COVID-19 pandemic and initiation of treatment for atrial fibrillation: a nationwide analysis of claims data.
Lanting YangShangbin TangMeiqi HeSerena Jingchuan GuoNico GabrielGretchen SwabeWalid F GelladUtibe R EssienSamir SabaEmelia J BenjaminJared W MagnaniInmaculada HernandezPublished in: BMC cardiovascular disorders (2023)
The COVID-19 pandemic did not affect the OAC initiation within 30 days of AF diagnosis but was associated with a decline in the provision of procedures for patients newly diagnosed with AF.
Keyphrases
- newly diagnosed
- atrial fibrillation
- end stage renal disease
- ejection fraction
- chronic kidney disease
- heart failure
- left atrial appendage
- oral anticoagulants
- catheter ablation
- left atrial
- palliative care
- health insurance
- big data
- cross sectional
- percutaneous coronary intervention
- combination therapy
- deep learning
- smoking cessation
- patient reported